What should you know about Ga-DOTATATE PET-CT?

Ga-DOTATATE is attached to gallium, a radioactive tracer, and binds to somatostatin receptors on many neuroendocrine tumour cells. The PET part detects the tracer’s signal, while CT shows the body’s anatomy so areas of uptake can be located more precisely. The scan can help find disease, assess its distribution, or clarify whether a treatment aimed at these receptors may be relevant. Uptake is interpreted with symptoms, blood tests, and other imaging.

Tell the nuclear medicine team if you are pregnant, breastfeeding, taking somatostatin medicines, or have difficulty lying still. Follow the centre’s instructions about food, drink, and medicines. A tracer is given through a vein, then you wait while it circulates before lying on the scanner bed. Keep still during image capture and drink fluids afterwards if advised. The team will explain any temporary radiation precautions relevant to your situation.

Tell staff immediately about pain, swelling, or itching at the injection site, dizziness, or feeling unwell during the visit. Seek urgent help for breathing difficulty, facial swelling, fainting, or severe weakness after leaving. These reactions are uncommon but need prompt attention. Contact the ordering team if you are unsure about medicine timing or cannot attend the scan.

Ask why Ga-DOTATATE was selected instead of another tracer, whether medicines need adjustment, what the scan can answer, and how the findings will affect the next decision.